Back to User profile » Dr Xuelei Ma

Papers published by Dr Xuelei Ma:

Original Research

The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study

Guo L, Ren H, Pu L, Zhu X, Liu Y, Ma X

Cancer Management and Research 2020, 12:7173-7188

Published Date: 13 August 2020

Original Research

The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma

Wang M, Wu S, Tong A, Cui X, Ma X

Cancer Management and Research 2019, 11:7981-7989

Published Date: 22 August 2019

Original Research

Proteomic analysis of cerebrospinal fluid in pediatric acute lymphoblastic leukemia patients: a pilot study

Guo L, Ren H, Zeng H, Gong Y, Ma X

OncoTargets and Therapy 2019, 12:3859-3868

Published Date: 17 May 2019

Original Research

Safety and efficacy of durvalumab (MEDI4736) in various solid tumors

Yang H, Shen K, Zhu C, Li Q, Zhao Y, Ma X

Drug Design, Development and Therapy 2018, 12:2085-2096

Published Date: 6 July 2018

Review

Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Zhang J, Li J, Zhu C, Song Y, Xia F, Ma X

Drug Design, Development and Therapy 2017, 11:3235-3244

Published Date: 15 November 2017

Original Research

Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials

Wang MN, Ma XL, Guo LH, Xia F

Drug Design, Development and Therapy 2017, 11:2851-2860

Published Date: 27 September 2017